Proceed with care: direct predictive testing for Huntington disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  American Journal of Human Genetics

• Publication date

  1994-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 7942838PMCID PMC1918294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Huntington disease without CAG expansion: phenocopies or errors in assignment?

  1994cited by this paper
• A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing.

  1994cited by this paper
• A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

  1994cited by this paper
• Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects

  1993cited by this paper
• 15th International World Federation of Neurology Workshop on Huntington's Disease, 31 August-3 September 1993, Boston, Massachusetts, USA.

  1993cited by this paper
• Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

  1993cited by this paper
• Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium.

  1993cited by this paper
• Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.

  1993cited by this paper
• Reluctance to undergo predictive testing: the case of Huntington disease.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• De novo expansion of a (CAG)n repeat in sporadic Huntington's disease

  1993cited by this paper
• Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.

  1993cited by this paper
• The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

  1993cited by this paper
• The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

  1993cited by this paper
• Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.

  1993cited by this paper
• Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases.

  1993cited by this paper
• Trinucleotide repeat length instability and age of onset in Huntington's disease

  1993cited by this paper
• Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.

  1993cited by this paper
• Discrimination as a consequence of genetic testing.

  1992cited by this paper
• Presymptomatic testing for huntington diseases: Recommendations for counseling

  1992cited by this paper
• Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

  1992cited by this paper
• Predictive testing for Huntington disease.

  1992cited by this paper
• Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

  1992cited by this paper
• Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.

  1992cited by this paper
• Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium.

  1992cited by this paper
• Opinion: predictive testing for Huntington disease in childhood: challenges and implications.

  1990cited by this paper
• Predictive testing for adult-onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease.

  1990cited by this paper
• Attitudes of general practitioners to presymptomatic testing for Huntington's disease.

  1990cited by this paper
• Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease.

  1990cited by this paper
• Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

  1989cited by this paper
• Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.

  1989cited by this paper
• Insurance and the presymptomatic diagnosis of delayed-onset disease.

  1989cited by this paper
• Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.

  1989cited by this paper
• World Federation of Neurology: Research Committee. Research Group on Huntington's chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test.

  1989cited by this paper
• A highly polymorphic locus very tightly linked to the Huntington's disease gene

  1988cited by this paper
• Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.

  1988cited by this paper
• Attitudes toward presymptomatic testing in Huntington disease.

  1987cited by this paper
• Psychiatric implications of presymptomatic testing for Huntington's disease.

  1987cited by this paper
• Intended use of predictive testing by those at risk for Huntington disease.

  1987cited by this paper
• Predictive testing.

  1986cited by this paper
• Presymptomatic testing for Huntington's disease.

  1985cited by this paper
• Huntington's disease

  1984cited by this paper
• A polymorphic DNA marker genetically linked to Huntington's disease

  1983cited by this paper
• Huntington's chorea

  1969cited by this paper
• Presymptomatic diagnosis.

  1967cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study

  year unknowncited by this paper

• Readers' perceptions of self-harm messages on social media

  2022cites this paper
• Huntington’s Disease Pathogenesis: Two Sequential Components

  2021cites this paper
• Prenatal and Preimplantation Genetic Diagnosis of Huntington's Disease

  2021cites this paper
• From the Patient’s Point of View: An Anthropological Response to Medicine’s Social Responsibility in Canadian Medical Education

  2021cites this paper
• Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System

  2020cites this paper
• Social and ethical issues regarding presymptomatic diagnosis A LITERATURE REVIEW

  2020cites this paper
• Gastrointestinal stress as innate defence against microbial attack

  2020cites this paper
• Improving follow up after predictive testing in Huntington’s disease: evaluating a genetic counselling narrative group session

  2019cites this paper
• Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

  2019cites this paper
• Therapeutic approaches to Huntington disease: from the bench to the clinic

  2018cites this paper
• All in the Family: Huntington’s Disease, Variability and Challenges for Clinical Neuropsychology

  2016cites this paper
• Predictive Diagnosis and Genetic Screening: Manipulation of Fate?

  2015cites this paper
• The cognitive and personality profiles of individuals who request preditive testing for Huntington's disease

  2014cites this paper
• Providing predictive testing for Huntington disease via telehealth: results of a pilot study in British Columbia, Canada

  2013cites this paper
• Recommendations for the predictive genetic test in Huntington's disease

  2013cites this paper
• [Current status of the predictive genetic testing for hereditary neurological diseases in Shinshu University Hospital].

  2013cites this paper
• HDBuzz: empowering patients through accessible education.

  2012cites this paper
• The Commercialization of Genetic Research

  2012cites this paper
• Genetic discrimination: international perspectives.

  2012cites this paper
• Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington disease

  2012cites this paper
• Genetic counselling implications for intermediate allele predictive test results for Huntington disease

  2012influential citation
• Recommendations for the predictive genetic test in Huntington ’ s disease

  2012cites this paper
• When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada

  2012cites this paper
• Experience over fifteen years with a protocol for predictive testing for Huntington disease.

  2011cites this paper
• Predictors of interest in direct-to-consumer genetic testing

  2011cites this paper
• IMPACTO PSICOSOCIAL DE PRUEBAS GENÉTICAS PREDICTIVAS EN ENFERMEDADES NEURODEGENERATIVAS DE INICIO TARDÍO (ATAXIA ESPINOCEREBELOSA TIPO 2 Y POLINEUROPATÍA AMILOIDÓTICA FAMILIAR ATTRV30M)

  2011cites this paper
• A grand challenge: Providing benefits of clinical genetics to those in need

  2011cites this paper
• Genetic counselling in neurology: a complex problem that requires regulation.

  2011cites this paper
• Genetic counselling in neurology: a complex problem that requires regulation.

  2011cites this paper
• Huntington disease : death, psychiatry and health services

  2009influential citation
• Presymptomatic Diagnosis in Huntington's Disease: The Mexican Experience

  2009cites this paper
• Medical ethics for the genome world: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

  2008cites this paper
• Attitudes Regarding Predictive Testing for Retinitis Pigmentosa

  2007cites this paper
• Nationwide survey on predictive genetic testing for late-onset, incurable neurological diseases in Japan

  2007cites this paper
• PRENATAL SCREENING: QUALITY CONTROL AND THE GENETICS GATEWAY

  2007cites this paper
• The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction

  2006cites this paper
• Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

  2006cites this paper
• Psychological aspects of pre‐symptomatic testing for Machado–Joseph disease and familial amyloid polyneuropathy type I

  2006cites this paper
• Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia

  2006cites this paper
• Organization of Genetic Services

  2004cites this paper
• Genetische Beratung und ihre Normen

  2004cites this paper
• Psychosocial impact of predictive testing for myotonic dystrophy type 1

  2004cites this paper
• Genes and geneticization? The social construction of autosomal dominant polycystic kidney disease

  2004cites this paper
• Testing the test—why pursue a better test for Huntington disease?

  2003cites this paper
• Aberrant A 2A receptor function in peripheral blood cells in Huntington's disease

  2003cites this paper
• Aberrant A2A receptor function in peripheral blood cells in Huntington's disease

  2003cites this paper
• Predictive testing for persons at risk for homozygosity for CAG expansion in the Huntington disease gene

  2003cites this paper
• Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future

  2003cites this paper
• The Psychological Dimension of Informed Consent: Dissonance Processes in Genetic Testing

  2003cites this paper
• Chapter 19 – Genetic Testing for Neurologic Disorders

  2003cites this paper
• Stories in Decisions: How At-Risk Individuals Decide to Request Predictive Testing for Huntington Disease

  2003cites this paper
• Predictive Testing for Huntington's Disease: How Does it Impact on Cognitive Performance?

  2002cites this paper
• Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy.

  2002cites this paper
• The spinocerebellar ataxias: Order emerges from chaos

  2002cites this paper
• Genetic testing for sale : implications of commercial BRCA testing in Canada

  2002cites this paper
• Ethics and Genetics: Susceptibility Testing in the Workplace

  2002cites this paper
• Homozygosity in Huntington's disease: new ethical dilemma caused by molecular diagnosis

  2002cites this paper
• Screening for Breast Cancer

  2002cites this paper
• intermediate and reduced penetrance New problems in testing for Huntington ' s disease :

  2001cites this paper
• Genetic counseling issues in predictive genetic testing for familial adult-onset neurologic diseases.

  2001cites this paper
• Ethical Issues in Health Care on the Frontiers of the Twenty-First Century

  2001cites this paper
• Presymptomatic tests in Huntington's disease and dominant ataxias

  2001cites this paper
• Beyond consent: ethical and social issues in genetic testing

  2001cites this paper
• Psychological effect of genetic testing for Huntington's disease: an update of the literature.

  2001cites this paper
• Genetic Counselling for Schizophrenia in the Era of Molecular Genetics

  2001cites this paper
• Onset and pre-onset studies to define the Huntington's disease natural history.

  2001cites this paper
• New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles

  2001cites this paper
• RB1 genetic testing as a clinical service: a follow-up study.

  2001cites this paper
• Concepts of Disease After the Human Genome Project

  2000cites this paper
• Molecular diagnosis of Huntington disease in Brazilian patients.

  2000cites this paper
• Predictive testing for Huntington's disease: the calm after the storm.

  2000cites this paper
• Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer

  2000cites this paper
• Paradox of a better test for Huntington's disease

  2000cites this paper
• United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington's disease

  2000cites this paper
• Family and molecular data for a fine analysis of age at onset in Huntington disease.

  2000cites this paper
• Genetic testing of adolescents: is it in their best interest?

  2000cites this paper
• Impact of genetic testing for Huntington disease on the family system.

  2000cites this paper
• Psychological impact of genetic testing for Huntington's disease: an update of the literature

  2000cites this paper
• Experience in prenatal testing for Huntington's disease in The Netherlands: procedures, results and guidelines (1987–1997)

  1999cites this paper
• Some Ethical Issues at the Population Level Raised by ‘Soft’ Eugenics, Euphenics, and Isogenics1

  1999cites this paper
• Genetic screening with the DNA chip: a new Pandora's box?

  1999cites this paper
• Traditional health outcomes in the evaluation of diagnostic tests.

  1999cites this paper
• Effects of Controllability, Predictability, and Information-Seeking Style on Interest in Predictive Genetic Testing

  1999cites this paper
• ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease

  1999cites this paper
• Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997).

  1999cites this paper
• Marketing and Fear Mongering

  1999cites this paper
• Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.

  1998cites this paper
• Bioethics for clinicians: 14. Ethics and genetics in medicine.

  1998cites this paper
• Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants.

  1998cites this paper
• ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group.

  1998cites this paper
• Laboratory Guidelines for Huntington Disease Genetic Testing

  1998cites this paper
• Psychological impact of screening for familial ovarian cancer: reactions to initial assessment.

  1997cites this paper
• Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA).

  1997cites this paper
• Psychological aspects of genetic counselling: a review of the experience with Huntington's disease.

  1997cites this paper
• Social work and genetic testing: Ethical issues encountered in predictive testing for Huntington disease

  1997cites this paper
• [Presymptomatic DNA diagnosis of spinocerebellar ataxia type 1].

  1997cites this paper
• Modified Method for the Detection of the CAG Repeat Expansion in Huntington's Disease and Application to a Predictive Testing Protocol.

  1997cites this paper
• Dilemmas of anonymous predictive testing for Huntington disease: privacy vs. optimal care.

  1997cites this paper
• Advances in molecular diagnosis.

  1996cites this paper
• Ethische Problematik prädiktiver genetischer Tests bei neurodegenerativen Erkrankungen

  1996cites this paper